Throughout the COVID-19 pandemic, Saint Luke’s Health System is committed to providing exceptional care for all patients and a safe and healthy atmosphere for our team.

A new drug is showing tremendous promise for patients with a common genetic heart condition, called hypertrophic cardiomyopathy.

Dr. John Spertus, Clinical Director of Outcomes Research at Saint Luke's Mid America Heart Institute, led phase 3 of the EXPLORER-HCM Clinical Trial, which evaluated how the medication impacted patients' quality of life.

KMBC talked to Dr. Spertus about the exciting results and one participant, Gary Frericks, who says it has changed his life.

Watch the full story below.

Read more >

Related Content

Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more >
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more >
Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more >